Virginia Sheikh1, Jeffrey S Murray1, Adam Sherwat1. Show Affiliations » 1. From the Division of Antiviral Products, Office of Antimicrobial Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD.
Abstract
Entities: Chemical
Mesh: See more » Anti-HIV Agents/therapeutic useAntibodies, Monoclonal/therapeutic useDisease ProgressionDrug Resistance, Multiple, ViralHIV Fusion Inhibitors/therapeutic useHIV Infections/drug therapyHumansResearch DesignUncertainty
Substances: See more » Anti-HIV AgentsAntibodies, MonoclonalHIV Fusion Inhibitorsibalizumab
Year: 2018 PMID: 30110580 DOI: 10.1056/NEJMp1808729
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245